Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

This study is ongoing, but not recruiting participants.

Study NCT00183248 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: September 11, 2005 Last Updated: May 13, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Kidney Diseases

More general conditions related to this trial

Interventions listed in this trial

Alemtuzumab
Mycophenolate mofetil
Sirolimus
Tacrolimus
Kidney transplant

Additional drug interventions recognized in this trial

Mycophenolic Acid

More general drug interventions related to this trial

Sponsors listed in this trial